Corium looks to go public for up to $50M; Researchers develop milk duct delivery method for breast cancer drugs;

> Transdermal delivery specialist Corium International filed with the Securities and Exchange Commission for an IPO expected to bring in about $50 million. Release

> A new delivery system developed at South Dakota State University is designed to deliver drugs through the milk ducts to reduce side effects and apply larger doses to affected tissue. More

> Sensile Medical completed a study for its semi-disposable patch pump for subcutaneous furosemide therapy. Release